These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24660521)

  • 41. Making the change to area under the curve-based vancomycin dosing.
    Heil EL; Claeys KC; Mynatt RP; Hopkins TL; Brade K; Watt I; Rybak MJ; Pogue JM
    Am J Health Syst Pharm; 2018 Dec; 75(24):1986-1995. PubMed ID: 30333114
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparison of 3 vancomycin dosage regimens during hemodialysis with cellulose triacetate dialyzers: post-dialysis versus intradialytic administration.
    Mason NA; Neudeck BL; Welage LS; Patel JA; Swartz RD
    Clin Nephrol; 2003 Aug; 60(2):96-104. PubMed ID: 12940611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections.
    Kitzis MD; Goldstein FW
    Clin Microbiol Infect; 2006 Jan; 12(1):92-5. PubMed ID: 16460555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A protocolized approach to vancomycin dosing in conventional hemodialysis.
    Panais R; Hirsch DJ; Dipchand C; Storsley L; Finkle SN
    J Nephrol; 2010; 23(5):569-74. PubMed ID: 20540035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vancomycin dosing in patients on intermittent hemodialysis.
    Vandecasteele SJ; De Vriese AS
    Semin Dial; 2011; 24(1):50-5. PubMed ID: 21338394
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vancomycin dosing nomograms targeting high serum trough levels in different populations: pros and cons.
    Elyasi S; Khalili H
    Eur J Clin Pharmacol; 2016 Jul; 72(7):777-88. PubMed ID: 27117446
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pitfalls in TDM of antibiotic drugs: analytical and modelling issues.
    Neef C; Touw DJ; Harteveld AR; Eerland JJ; Uges DR
    Ther Drug Monit; 2006 Oct; 28(5):686-9. PubMed ID: 17038886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced vancomycin clearance despite unchanged creatinine clearance in patients treated with vancomycin for longer than 4 weeks.
    Nakayama H; Echizen H; Tanaka M; Sato M; Orii T
    Ther Drug Monit; 2008 Feb; 30(1):103-7. PubMed ID: 18223471
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic drug monitoring of vancomycin in a morbidly obese patient.
    Penzak SR; Gubbins PO; Rodvold KA; Hickerson SL
    Ther Drug Monit; 1998 Jun; 20(3):261-5. PubMed ID: 9631922
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vancomycin prescription in neonates and young infants: toward a simplified dosage.
    Oudin C; Vialet R; Boulamery A; Martin C; Simon N
    Arch Dis Child Fetal Neonatal Ed; 2011 Sep; 96(5):F365-70. PubMed ID: 21378399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
    Truong J; Levkovich BJ; Padiglione AA
    Intern Med J; 2012 Jan; 42(1):23-9. PubMed ID: 22276559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vancomycin levels: to draw or not to draw.
    Creekmore F
    S D J Med; 1998 Jun; 51(6):195-6. PubMed ID: 9646718
    [No Abstract]   [Full Text] [Related]  

  • 53. Antibiotic dosing during sustained low-efficiency dialysis: special considerations in adult critically ill patients.
    Bogard KN; Peterson NT; Plumb TJ; Erwin MW; Fuller PD; Olsen KM
    Crit Care Med; 2011 Mar; 39(3):560-70. PubMed ID: 21221000
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictive performance of pharmacokinetic models for outpatients receiving vancomycin continuous infusion.
    Ng TM; Lye DC; Chan M; Tam VH
    Int J Antimicrob Agents; 2014 Feb; 43(2):197-9. PubMed ID: 24359843
    [No Abstract]   [Full Text] [Related]  

  • 55. Factors associated with inadequate early vancomycin levels in critically ill patients treated with continuous infusion.
    De Waele JJ; Danneels I; Depuydt P; Decruyenaere J; Bourgeois M; Hoste E
    Int J Antimicrob Agents; 2013 May; 41(5):434-8. PubMed ID: 23410793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protocol for a randomised controlled trial of continuous infusions of vancomycin to improve the attainment of target vancomycin levels in young infants: The VANC trial.
    Gwee A; Cranswick N; Donath SM; Hunt R; Curtis N
    BMJ Open; 2018 Nov; 8(11):e022603. PubMed ID: 30391914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of dialysis membrane on intradialytic vancomycin administration.
    Scott MK; Macias WL; Kraus MA; Clark WR; Carfagna MA; Mueller BA
    Pharmacotherapy; 1997; 17(2):256-62. PubMed ID: 9085316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
    Roberts DM; Roberts JA; Roberts MS; Liu X; Nair P; Cole L; Lipman J; Bellomo R;
    Crit Care Med; 2012 May; 40(5):1523-8. PubMed ID: 22511133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Importance of Individualized Vancomycin Dosing to Ensure Optimal Exposure Early in Therapy.
    Zasowski EJ; Lodise TP
    J Clin Pharmacol; 2018 Sep; 58(9):1131-1133. PubMed ID: 30024648
    [No Abstract]   [Full Text] [Related]  

  • 60. Intravenous administration of vancomycin is ineffective against bacteremia following tooth extraction.
    Kaneko A; Sasaki J; Yamazaki J; Kobayashi I
    Tokai J Exp Clin Med; 1995 May; 20(1):65-6. PubMed ID: 8869455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.